Timothy Kieffer
Hoofd Techniek/Wetenschap/O&O bij FRACTYL HEALTH, INC.
Vermogen: - $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Harith Rajagopalan | M | 48 | 14 jaar | |
| Jay Caplan | M | 63 | 14 jaar | |
| Amy Schulman | F | 63 | 6 jaar | |
| Kelly Barnes | F | 58 | 2 jaar | |
| Jon Fitzgerald | M | - | 12 jaar | |
| Marc Elia | M | 48 | 3 jaar | |
| Ajay Royan | M | 45 | 10 jaar | |
| Sarah S. Toomey | F | 50 | 2 jaar | |
| Clive Meanwell | M | 67 | 3 jaar | |
| Lisa Davidson | F | 58 | 9 jaar | |
| Bill Bradley | M | 80 | 7 jaar | |
| Samuel Conaway | M | - | - | |
| Allan Roger Will | M | 70 | 12 jaar | |
| Len Rosberg | M | - | - | |
| Lisa Porter | M | 60 |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 2 jaar |
| Helmut Giersiefen | M | 66 | - | |
| Kelly White | M | - | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Ian Smith | M | 58 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 3 jaar |
| Fred Middleton | M | 74 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 23 jaar |
| Brittany Bradrick | F | 54 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 1 jaar |
| Mark Foletta | M | 63 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 9 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 21 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Timothy Kieffer
- Persoonlijk netwerk
